Malignant hypertension complicated by acute renal failure

BMJ Case Reports

Volumn , Issue , 2009, Pages

  Li, Xiao ^a   Zhang, Wen ^a   Ren, Hong ^a   Pan, Xiaoxia ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896502238     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.10.2008.1116     Document Type: Article

References (14)

1. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356: 411-7.
2. Shibagaki Y, Fujit T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Hypertens Res 2005; 31: 89-95.
3. Patel A, Patel H, Patel A, et al. Thrombotic thrombocytopenic purpura: the masquerader. South Med J 2009; 102: 504-9.
4. Zhang B, Xing CY, Yu XB, et al. Renal thrombotic microangiopathies induced bysevere hy pertension. Hypertens Res 2008; 31: 479-83.
5. Douglas JG, Agodoa L. ACE inhibition is effective and renoprotective in hy pertensive nephrosclerosis: the Af rican American Studyof Kidney Disease and Hy pertension (AASK) trial. Kidney Int 2003; 63: S74-6.
6. Therrien F, Lemieux P, Bélanger S, et al. Protective effects of angiotensin AT(1) receptor blockade in malignant hy pertension in the rat. Eur J Pharmacol 2009; 607: 126-34.
7. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hy pertension: the Task Force for the Management of Arterial Hy pertension of the European Societyof Hy pertension (ESH) and of the European Societyof Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
8. Neutel JM. The role of combination therapy in the management of hy pertension. Nephrol Dial Transplant 2006; 21: 1469-74.
9. Sommerfeld DL, Brennan DC, Gordon JA. Thrombotic microangiopathy : a case report and review of the literature. J Am Soc Nephrol 1992; 3: 35-41.
10. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
11. Ferrara F, Copia C, Annunziata M, et al. Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura. Ann Hematol 1999; 78: 521-3.
12. van den Born BJ, van der Hoeven NV, Groot E, et al. Association between thrombotic microangiopathy and reduced ADAMTS13. Hypertension 2008; 51: 862-6.
13. Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008; 112: 11-8.
14. Michael M.,Elliott E.J.,Craig J.C.,et al.,Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: A systematic review of randomized controlled trials Am J Kidney Dis 2009 53 259-273